What type of study is this?

This is a Pre-Registered Trial study.

What question did this study set out to answer?

To evaluate the efficacy of romiplostim in treating chemotherapy-induced thrombocytopenia (CIT) compared to placebo.

View Full Paper

Ask AI

Bookmark

To evaluate the efficacy of romiplostim in treating chemotherapy-induced thrombocytopenia (CIT) compared to placebo.
Phase 3, placebo-controlled trial design
Participants with chemotherapy-induced thrombocytopenia
Comparison of treatment effects between romiplostim and placebo
Romiplostim showed efficacy in treating CIT compared to placebo

No takes yet. Share an insight, caveat, or question.

Phase 3 trial demonstrates romiplostim improved outcomes in chemotherapy-induced thrombocytopenia, suggesting new treatment options.

Al-Samkari et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark